51.591.40% ( -0.73 )
Delay Closed: Nov 17, 15:00:00Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: R&G Pharma(301333) the Revenue is 245.83 M (+7.96%);the EBIT is 28.46 M (-22.16%);the EPS is 0.333 (-7.42%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.25B7.96%
----
----
EBIT
0.03B22.16%
----
----
EPS
0.33327.42%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 26, 2027
Estimate Revenue975 M
Estimate EBIT190 M
Estimate EPS1.73
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
